A novel therapy for the prevention and treatment of familial hypertrophic cardiomyopathy [ 2016 - 2019 ]

Research Grant

Researchers: A/Pr Livia Hool (Principal investigator) ,  A/Pr Killugudi Swaminatha-Iyer ,  Prof Christopher Semsarian

Brief description Familial hypertrophic cardiomyopathy is a genetic disorder that leads to enlargement of the heart, cardiac failure and sudden death. No treatment exists that can reverse or prevent the cardiomyopathy. In this proposal we will determine whether a peptide (Patent WO2013/113060) targeting a calcium channel can prevent or reverse the cardiomyopathy as a novel treatment for the disease.

Funding Amount $AUD 862,592.98

Funding Scheme Project Grants

Notes Standard Project Grant